Syndromes Without a Name Bring Labs an Uphill Battle
In an era when genetic and genomic testing are theoretically affordable and accessible, why do so many patients remain undiagnosed?
In an era when genetic and genomic testing are theoretically affordable and accessible, why do so many patients remain undiagnosed?
From - Diagnostic Testing & Emerging Technologies
Televised direct-to-consumer advertising (DTCA) is associated with greater testosterone testing, according to a study published March 21 in the Journal of the American Medical Association…
From - Diagnostic Testing & Emerging Technologies
There was an uptick in preventive screening after enactment of the Affordable Care Act (ACA), yet cancer-screening rates in the United States remain below…
From - Diagnostic Testing & Emerging Technologies
Two recent testing guidelines were released that address carrier screenings for pregnant women and a rare disease lacking a…
From - Diagnostic Testing & Emerging Technologies
A joint guideline from the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and…